Insider Buying: Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Acquires $23,880.00 in Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack bought 1,500 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The shares were acquired at an average price of $15.92 per share, with a total value of $23,880.00. Following the purchase, the director now owns 60,583 shares in the company, valued at $964,481.36. This trade represents a 2.54 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Catherine Cusack also recently made the following trade(s):

• On Friday, February 21st, Catherine Cusack purchased 1,000 shares of Sabra Health Care REIT stock. The stock was purchased at an average cost of $16.43 per share, with a total value of $16,430.00.

Sabra Health Care REIT Trading Up 0.4 %

Shares of SBRA opened at $16.45 on Friday. Sabra Health Care REIT, Inc. has a 1 year low of $13.31 and a 1 year high of $20.03. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock has a 50 day simple moving average of $16.78 and a 200-day simple moving average of $17.61. The stock has a market cap of $3.91 billion, a PE ratio of 31.04, a PEG ratio of 1.97 and a beta of 1.25.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The business had revenue of $182.35 million during the quarter, compared to analysts’ expectations of $178.01 million. On average, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 7.29%. Sabra Health Care REIT’s dividend payout ratio is 226.42%.

Institutional Investors Weigh In On Sabra Health Care REIT

A number of hedge funds and other institutional investors have recently bought and sold shares of SBRA. Creative Planning increased its holdings in Sabra Health Care REIT by 8.9% during the 3rd quarter. Creative Planning now owns 24,284 shares of the real estate investment trust’s stock valued at $452,000 after purchasing an additional 1,992 shares in the last quarter. International Assets Investment Management LLC increased its holdings in Sabra Health Care REIT by 1,761.0% during the 3rd quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 5,776 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in Sabra Health Care REIT by 34.8% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,985 shares of the real estate investment trust’s stock valued at $166,000 after purchasing an additional 2,318 shares in the last quarter. Vanderbilt University acquired a new stake in Sabra Health Care REIT during the 3rd quarter valued at $1,647,000. Finally, abrdn plc increased its holdings in Sabra Health Care REIT by 58.2% during the 3rd quarter. abrdn plc now owns 875,495 shares of the real estate investment trust’s stock valued at $16,293,000 after purchasing an additional 322,255 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have commented on SBRA. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Finally, JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a report on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.